-
Teva receives FDA nod for QVAR
JERUSALEM — Teva Pharmaceutical on Friday announced that the Food and Drug Administration approved the use of QVAR (beclomethasone dipropionate HFA) with a dose counter for the treatment of asthma in patients 5 years of age and older.
The counter will help asthma patients and their caregivers keep track of the number of remaining doses in the canister. It will be commercially available later this year, according to the company.
-
Nestlé Crunch Girl Scout Candy Bars to return to shelves
LOS ANGELES — Nestlé Crunch announced that its Nestlé Crunch Girl Scout Candy Bars will be making a return appearance nationwide beginning in June. The bars were first introduced to consumers in 2012 and were awarded the Best New Product accolade by Better Homes & Gardens.